Conventional therapy for Crohn’s disease

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 30

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

382

HTML

2488

Tables (1-7)

210

Sum=3080

Aug 14, 2006 (publication date) through Nov 24, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Aug 14, 2006; 12(30): 4794-4806
Published online Aug 14, 2006. doi: 10.3748/wjg.v12.i30.4794

Table 5 Drugs for the treatment of CD

Drug	Metronidazole
Dosage	10-20 mg/kg
Indications	Mild to moderately active disease; fistulae (usually prolonged treatment)
Important side effects	Nausea, metallic taste in the mouth, coating of the tongue, peripheral neuropathy
Monitoring	See side effects
Pregnancy	Long term treatment not yet evaluated, short term treatment appears to be safe

Citation: Büning C, Lochs H. Conventional therapy for Crohn’s disease. World J Gastroenterol 2006; 12(30): 4794-4806
URL: https://www.wjgnet.com/1007-9327/full/v12/i30/4794.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i30.4794